Scarica l'app Stockscreener
14.36
2.57%
0.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$14.00
Aprire:
$14.17
Volume 24 ore:
1.86M
Relative Volume:
0.89
Capitalizzazione di mercato:
$970.30M
Reddito:
$796.00M
Utile/perdita netta:
$-136.49M
Rapporto P/E:
-6.8708
EPS:
-2.09
Flusso di cassa netto:
$-64.24M
1 W Prestazione:
-3.88%
1M Prestazione:
-2.38%
6M Prestazione:
-33.15%
1 anno Prestazione:
-55.00%
Intervallo 1D:
$13.69
$14.42
Intervallo di 1 settimana:
$13.66
$15.51
Portata 52W:
$9.98
$38.28
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Confronta TNDM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
14.36 | 945.97M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Ripresa | Stifel | Hold |
| 2025-09-08 | Iniziato | Oppenheimer | Outperform |
| 2025-08-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Downgrade | Citigroup | Neutral → Sell |
| 2025-06-16 | Iniziato | Truist | Hold |
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2025-03-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-03-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Chart overlay techniques for tracking Tandem Diabetes Care Inc.2025 Trading Recap & AI Driven Price Predictions - newser.com
Earnings visualization tools for Tandem Diabetes Care Inc.2025 Price Targets & AI Forecast Swing Trade Picks - newser.com
Can Tandem Diabetes Care Inc. stock hit analyst price targetsPortfolio Growth Summary & Stepwise Trade Execution Plans - newser.com
Combining machine learning predictions for Tandem Diabetes Care Inc.July 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Pattern recognition hints at Tandem Diabetes Care Inc. upsideWeekly Risk Report & Risk Controlled Daily Plans - newser.com
What indicators show strength in Tandem Diabetes Care Inc.Earnings Growth Report & Entry Point Strategy Guides - newser.com
Is Tandem Diabetes Care Inc. stock supported by innovation pipelineRisk Management & Verified Technical Signals - newser.com
Why Analysts Are Rethinking the Story Behind Tandem Diabetes Care After Recent Developments - Yahoo Finance
How Tandem Diabetes Care Inc. stock compares to industry benchmarksRate Hike & Verified Chart Pattern Signals - newser.com
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Real time pattern detection on Tandem Diabetes Care Inc. stockSwing Trade & Technical Pattern Based Buy Signals - newser.com
Tandem Diabetes Care (TNDM): Examining the Valuation After a Challenging Year and Recent Rebound - Sahm
Is Tandem Diabetes Care Inc. stock a buy on dipsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Will Tandem Diabetes Care Inc. (TD5A) stock outperform value peersEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Using data models to predict Tandem Diabetes Care Inc. stock movementWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
How supply chain issues affect Tandem Diabetes Care Inc. stock2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
Tandem Diabetes Care announces upcoming conference presentations - MarketScreener
Tandem Diabetes Stock Falls on DexCom ForecastMarket Update 2025News and Statistics - IndexBox
Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today - Yahoo Finance
Tandem Diabetes Care Announces Upcoming Conference Presentations - Yahoo Finance
Is Tandem Diabetes Care Inc. (TD5A) stock a contrarian opportunityTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Can you recover from losses in Tandem Diabetes Care Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com
Is Tandem Diabetes Care Inc. still worth holding after the dipPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Will Tandem Diabetes Care Inc. stock recover after recent dropJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Why Tandem Diabetes Care Inc. stock is recommended by analystsQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Tandem Diabetes Care Launches t:slim X2 Pump Integration with Abbott FreeStyle Libre 3 Plus Sensor - HIT Consultant
Using R and stats models for Tandem Diabetes Care Inc. forecastingPortfolio Return Report & Stepwise Swing Trade Plans - newser.com
Market Might Still Lack Some Conviction On Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even After 26% Share Price Boost - simplywall.st
Tandem Rolls Out t:slim X2 Insulin Pump with Abbott’s FreeStyle Libre 3 Plus - Medical Product Outsourcing
t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Li - GuruFocus
T:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States - MarketScreener
t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States - Yahoo Finance
Implantable Insulin Pumps Market Size reached US$ 3.2 Billion - openPR.com
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):